Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

249 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Multi-Target Approaches in Metabolic Syndrome.
Lillich FF, Imig JD, Proschak E. Lillich FF, et al. Among authors: imig jd. Front Pharmacol. 2021 Mar 12;11:554961. doi: 10.3389/fphar.2020.554961. eCollection 2020. Front Pharmacol. 2021. PMID: 33776749 Free PMC article. Review.
Dual soluble epoxide hydrolase inhibitor/PPAR-γ agonist attenuates renal fibrosis.
Stavniichuk A, Hye Khan MA, Yeboah MM, Chesnik MA, Jankiewicz WK, Hartmann M, Blöcher R, Kircher T, Savchuk O, Proschak E, Imig JD. Stavniichuk A, et al. Among authors: imig jd. Prostaglandins Other Lipid Mediat. 2020 Oct;150:106472. doi: 10.1016/j.prostaglandins.2020.106472. Epub 2020 Jun 20. Prostaglandins Other Lipid Mediat. 2020. PMID: 32569747
Multi-Target Drugs for Kidney Diseases.
Imig JD, Merk D, Proschak E. Imig JD, et al. Kidney360. 2021 Aug 2;2(10):1645-1653. doi: 10.34067/KID.0003582021. eCollection 2021 Oct 28. Kidney360. 2021. PMID: 35372984 Free PMC article.
Pharmacological Blockade of Soluble Epoxide Hydrolase Attenuates the Progression of Congestive Heart Failure Combined With Chronic Kidney Disease: Insights From Studies With Fawn-Hooded Hypertensive Rats.
Vacková Š, Kopkan L, Kikerlová S, Husková Z, Sadowski J, Kompanowska-Jezierska E, Hammock BD, Imig JD, Táborský M, Melenovský V, Červenka L. Vacková Š, et al. Among authors: imig jd. Front Pharmacol. 2019 Jan 23;10:18. doi: 10.3389/fphar.2019.00018. eCollection 2019. Front Pharmacol. 2019. PMID: 30728778 Free PMC article.
Epoxyeicosatrienoic Acid-Based Therapy Attenuates the Progression of Postischemic Heart Failure in Normotensive Sprague-Dawley but Not in Hypertensive Ren-2 Transgenic Rats.
Hrdlička J, Neckář J, Papoušek F, Husková Z, Kikerlová S, Vaňourková Z, Vernerová Z, Akat F, Vašinová J, Hammock BD, Hwang SH, Imig JD, Falck JR, Červenka L, Kolář F. Hrdlička J, et al. Among authors: imig jd. Front Pharmacol. 2019 Mar 1;10:159. doi: 10.3389/fphar.2019.00159. eCollection 2019. Front Pharmacol. 2019. PMID: 30881303 Free PMC article.
249 results